I had considered FDA submission dead and buried, but this may put them in a position to show benefits outweigh risks depending on gathered data and doctor testimonies
Ann: ResAppDx-EU in Use at COVID-19 Respiratory Clinic, page-90
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #